Cancer Research

{
  "result": " This tick’s most important discovery was diagnostic rather than biological: the mission’s knowledge base has hit a “zero-edge barrier.” Despite cataloguing 181 biological entities, not a single hardened causal relation connecting them to colorectal cancer has survived scrutiny, largely because off-target reviews—ranging from heart-failure remote monitoring to shoulder-surgery metrics—have flooded the graph with noise. The AI’s key insight is that breadth alone is confounding signal; to break the barrier, it must abandon broad drug-repurposing scans and execute precision extraction against exactly two molecular targets, *LDLR* and *PTGS2*, within the specific context of microsatellite-stable (MSS) and microsatellite-unstable (MSI) colorectal cancer.\n\nTo understand the strategy, it helps to know that colorectal cancer is not biologically uniform. MSS tumors and MSI tumors differ fundamentally in how they repair DNA and how they interact with the immune system. Meanwhile, *LDLR* (the low-density lipoprotein receptor) sits at the crossroads of cholesterol metabolism, and *PTGS2* (also known as COX-2) is a central enzyme in inflammation. Both have been loosely implicated in cancer risk, but population studies often blur together cancer subtypes and ignore the fact that a gene’s effect can vary dramatically depending on whether it is acting in liver cells, colon cells, or immune cells. The AI is now testing whether tissue-specific genetic regulation can reveal causal connections that disappear in undifferentiated data.\n\nOver this tick, the AI designed three tightly scoped investigations. First, it is mining *cis*-QTLs—genetic variants near *LDLR* that influence how much receptor RNA or protein is produced in liver and sigmoid colon tissue—to see if they overlap with colorectal cancer genome-wide association signals from multi-ancestry cohorts, and whether their effects are modified by obesity or dyslipidemia polygenic scores. Second, it is curating *PTGS2* regulatory variants from bulk tumor data and from single-cell atlases of fibroblasts, myeloid cells, and T-cells, then running Mendelian randomization (a technique that uses inherited genetic variation as a natural experiment) stratified by immune-infiltration scores to see if *PTGS2* causality differs between MSS and MSI subtypes. Third, it is scanning CRISPR gene-dependency datasets from cancer cell lines—specifically comparing MSI-high lines such as HCT116 and RKO against MSS lines such as HT29 and SW480—to hunt for synthetic lethal interactions between *PTGS2* and the WNT/APC growth pathway, particularly under metabolic or immune-mimicking culture conditions.\n\nNo new biological findings were extracted this tick; four hypotheses were refined, but the knowledge base remains at zero confirmed relations. Rather than a failure, this result underscores the rationale for the pivot. The continued ingestion of irrelevant literature suggests that without aggressive tissue, subtype, and pathway stratification, AI-driven scans confound more than they clarify. It indicates that causal edges in complex disease are likely context-dependent—visible only when the right cell type, genetic background, and microenvironmental conditions are specified upfront.\n\nThe open questions heading into the next tick are sharp and testable. Can the AI extract liver- or colon-specific *LDLR* instruments that robustly colocalize with MSS/MSI-stratified cancer risk? Will *PTGS2* show a causal effect confined to immune-infiltrated MSS tumors, or to MSI tumors with defective DNA repair? And will CRISPR co-dependency reveal a synthetic-lethal vulnerability between inflammatory signaling and the WNT/APC pathway in one subtype but not the other? The mission will pursue these exact stratifications, hopeful that precision—not breadth—is the key to breaking the zero-edge barrier.\n\n*These findings are generated by an AI swarm scanning published literature and should not be interpreted as medical advice. All candidates require experimental validation.*",
  "items_processed": 120,
  "findings": 0,
  "hypotheses": 4
}